Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.49 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | F11 | P03951 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.45 |
| ▸ | PDE5A | O76074 | 1/20 | 0.45 |
| ▸ | HMGCR | P04035 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | FYN | P06241 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1726977 | 1.00 | USP2 (0.54) | USP2POLBMEN1KMT2APTPN1 | |
| SCHEMBL17620221 | 1.00 | USP2 (0.54) | USP2POLBMEN1KMT2APTPN1 | |
| SCHEMBL17620173 | 1.00 | USP2 (0.54) | USP2POLBMEN1KMT2APTPN1 | |
| SCHEMBL17620209 | 1.00 | USP2 (0.54) | USP2POLBMEN1KMT2APTPN1 | |
| SCHEMBL3663518 | 1.00 | USP2 (0.54) | USP2POLBMEN1KMT2APTPN1 | |
| SCHEMBL1728378 | 1.00 | USP2 (0.54) | USP2POLBMEN1KMT2APTPN1 | |
| SCHEMBL6022376 | 1.00 | USP2 (0.54) | USP2POLBMEN1KMT2APTPN1 | |
| SCHEMBL3663517 | 1.00 | USP2 (0.54) | USP2POLBMEN1KMT2APTPN1 | |
| SCHEMBL14103187 | 1.00 | USP2 (0.54) | USP2POLBMEN1KMT2APTPN1 | |
| SCHEMBL2493929 | 0.99 | USP2 (0.55) | USP2POLBMEN1KMT2APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200181187-A1 | PROCESS FOR THE PREPARATION OF (S,S)-SECOISOLARICIRESINOL DIGLUCOSIDE AND (R,R)-SECOISOLARICIRESINOL DIGLUCOSIDE | LIGNAMED LLC (US) | 2020-06-11 | — | — | US | disclosed |
| EP-3638220-A1 | PROCESS FOR THE PREPARATION OF (S,S | LignaMed, LLC (US) | 2020-04-22 | — | — | EP | disclosed |
| WO-2018231691-A1 | PROCESS FOR THE PREPARATION OF (S,S)-SECOISOLARICIRESINOL DIGLUCOSIDE AND (R,R)-SECOISOLARICIRESINOL DIGLUCOSIDE | LIGNAMED, LLC (US) | 2018-12-20 | — | — | WO | disclosed |
| WO-2018136620-A2 | ENDOSOMAL CLEAVABLE LINKERS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2018-07-26 | — | — | WO | disclosed |
| US-20150050367-A1 | TIMOSAPONIN COMPOUNDS | GOLDPORP PHARMA LIMITED (HK) | 2015-02-19 | — | — | US | disclosed |
| US-20120003260-A1 | Solid-Phase and Solution-Phase Synthesis of Glycosylphosphatidylinositol Glycans | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-01-05 | — | — | US | disclosed |
| US-7943594-B2 | Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-05-17 | — | — | US | disclosed |
| US-20080171706-A1 | Anti-Adhesive Compounds to Prevent and Treat Bacterial Infections | VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW (BE) | 2008-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150050367-A1 | TIMOSAPONIN COMPOUNDS | APP, IAPP, BACE1 | USP2 4673/4885POLB 3050/4885MEN1 1058/4885 |
| US-20200181187-A1 | PROCESS FOR THE PREPARATION OF (S,S)-SECOISOLARICIRESINOL DIGLUCOSIDE AND (R,R)-SECOISOLARICIRESINOL DIGLUCOSIDE | LSS, STS, SRM | USP2 2142/4885POLB 1943/4885MEN1 3381/4885 |
| US-20080171706-A1 | Anti-Adhesive Compounds to Prevent and Treat Bacterial Infections | EPCAM, ICAM1, CDH1 | USP2 2700/4885POLB 3062/4885MEN1 2598/4885 |
| US-20120003260-A1 | Solid-Phase and Solution-Phase Synthesis of Glycosylphosphatidylinositol Glycans | GPI, ALG1, FUT5 | USP2 3948/4885POLB 2464/4885MEN1 1868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.